Replies to post #24546 on $heff's $tation of $tocks & $olid DD

[longnshort]

Monday announcement, I like that. Could be good news. Unlike Friday after 4pm announcements.

[$heff]

Alert...bought shares of BNVI at .496 in the Starter Portfolio this afternoon based on the scheduled conf call for next week and the pipeline of the company being undervalued in my view & opinion. $heff

Message in reply to:

BNVI News!
Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
prnewswire

Companies:
o Bionovo, Inc.
Press Release Source: Bionovo, Inc. On Monday March 8, 2010, 4:00 pm

EMERYVILLE, Calif., March 8 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq:BNVI - News) announced today that it will release financial results for the fourth quarter and fiscal year 2009 ended December 31, 2009 on Monday, March 15, 2010. The Company will conduct a conference call and web cast to review the financial results on Monday, March 15, 2010 at 5:00 p.m. ET.

Interested parties can access the call by dialing [phone] or [phone], or can listen via a live Internet web cast, which can be found at http://bionovo.com/investors/events. A replay of the call will be available via web cast at http://bionovo.com/investors/events or by playback at [phone] or [phone], conference code 438591, through March 18, 2010.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.